Related Experiment Video
Updated: Apr 10, 2026
05:07
Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
1.4K
Biomarkers in descending thoracic aortic dissection
Sherene Shalhub1, Anahita Dua2, Jared Brooks1
1Division of Vascular Surgery, Department of Surgery, University of Washington, 1959 NE Pacific Street, Box 356410, Seattle, WA 98195-6410.
Seminars in Vascular Surgery
|June 16, 2015
Summary
Serum biomarkers like d-dimer and C-reactive protein show potential for predicting thoracic aortic dissection outcomes. Further research is needed to clarify their clinical use in patient management.
Area of Science:
- Cardiovascular Medicine
- Biomarker Research
- Thoracic Surgery
Background:
- Descending thoracic aortic dissection (DTAD) is a life-threatening condition.
- Predicting the natural history and complications of DTAD is clinically challenging.
- Current diagnostic and prognostic tools for DTAD require enhancement.
Purpose of the Study:
- To review the current understanding of serum biomarkers in DTAD.
- To assess the role of biomarkers in DTAD detection.
- To evaluate biomarker utility in predicting DTAD complications and guiding patient management.
Main Methods:
- Systematic literature review of studies on serum biomarkers and DTAD.
- Analysis of data on d-dimer and C-reactive protein in DTAD.
- Synthesis of evidence regarding biomarker application in clinical settings.
Main Results:
- Serum biomarkers, including d-dimer and C-reactive protein, are being investigated for their role in DTAD.
- Evidence suggests potential utility for these biomarkers in detecting DTAD and predicting its course.
- The precise clinical application for predicting complications and managing patients remains under investigation.
Conclusions:
- Serum biomarkers hold promise for improving the management of descending thoracic aortic dissection.
- Further research is essential to establish robust clinical guidelines for biomarker use in DTAD.
- Biomarkers may offer future avenues for risk stratification and personalized treatment strategies in DTAD.
More Related Videos
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
1.2K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
544
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
544
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
966
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
966
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
778
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
778
01:30Acute Coronary Syndrome III: Diagnostic Studies
461
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
461
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
688
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
688